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Abstract
Background: In the recent years, there has been a rise in gene expression profiling reports. Unfortunately, it has
not been possible to make maximum use of available gene expression data. Many databases and programs can be
used to derive the possible expression patterns of mammalian genes, based on existing data. However, these
available resources have limitations. For example, it is not possible to obtain a list of genes that are expressed in
certain conditions. To overcome such limitations, we have taken up a new strategy to predict gene expression
patterns using available information, for one tissue at a time.
Results: The first step of this approach involved manual collection of maximum data derived from large-scale
(genome-wide) gene expression studies, pertaining to mammalian testis. These data have been compiled into a
Mammalian Gene Expression Testis-database (MGEx-Tdb). This process resulted in a richer collection of gene
expression data compared to other databases/resources, for multiple testicular conditions. The gene-lists collected
this way in turn were exploited to derive a ‘consensus’ expression status for each gene, across studies. The
expression information obtained from the newly developed database mostly agreed with results from multiple
small-scale studies on selected genes. A comparative analysis showed that MGEx-Tdb can retrieve the gene
expression information more efficiently than other commonly used databases. It has the ability to provide a clear
expression status (transcribed or dormant) for most genes, in the testis tissue, under several specific physiological/
experimental conditions and/or cell-types.
Conclusions: Manual compilation of gene expression data, which can be a painstaking process, followed by a
consensus expression status determination for specific locations and conditions, can be a reliable way of making
use of the existing data to predict gene expression patterns. MGEx-Tdb provides expression information for 14
different combinations of specific locations and conditions in humans (25,158 genes), 79 in mice (22,919 genes)
and 23 in rats (14,108 genes). It is also the first system that can predict expression of genes with a ‘reliability-score’,
which is calculated based on the extent of agreements and contradictions across gene-sets/studies. This new
platform is publicly available at the following web address: http://resource.ibab.ac.in/MGEx-Tdb/
Background
Establishing gene expression patterns would facilitate
understanding of almost every aspect of cellular and
molecular biology. Since mass scale detection is easier
in case of mRNAs than proteins, many studies have
considered gene expression determination at the tran-
script level. These reports have resulted in large number
of signature sets of genes corresponding to various
experimental/physiological conditions and tissues/cell-
types of multiple species. The phrase ‘gene-sets’ is used
in this article to refer to the data-sets, which usually
have a large list of genes with additional expression
values, as well as the simpler gene-lists, which are a
smaller set of genes, and usually without additional data.
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gene-expression data. The main types of data considered
by such databases include: Expressed Sequence Tags
(ESTs) (e.g., UniGene [1]), microarray (e.g., BioGPS,
earlier SymAtlas [2]), Serial Analysis of Gene Expression
(SAGE) (e.g., GermSAGE [3]) and manually curated
information from different small scale experiments (e.g.,
Human Protein Reference Database or HPRD [4]). The
majority of these databases can extract and display the
expression-related data for genes in multiple species, tis-
sues and conditions. However, our preliminary observa-
tions showed that the transcription patterns of genes
revealed by different databases frequently contradict
each other.
Further, the reproducibility of data from microarray is
questionable in spite of the fact that this is the most
common expression profiling technique used [5-9].
Hence, it is preferable to derive a ‘consensus’ expression
status for genes by comparing the data-sets from com-
parable conditions and tissues/cell-types, rather than
relying on one study only. It is possible to derive a sim-
ple expression status (expressed or not expressed) for
conditions or tissues, for which multiple data-sets are
available. However, such simple expression profiles can-
not be retrieved by the existing databases, even when
the expression data for the corresponding conditions/
locations is available. This is because of the following
reasons:
a) Some of the published microarray data do not seem to
be covered by the existing repositories/databases. For
example, the raw data is not deposited in a significant
number of cases [10]. The smaller gene-lists, which are
sometimes the only gene-sets reported for specific condi-
tions/cell-types, are particularly ignored by most databases,
with exceptions such as Oncomine [11], which focuses on
human cancer data alone. The microarray data corre-
sponding to some studies such as the effects of androgen
deprivation [12], FSH treatment [13], and testicular carci-
noma [14] were not found in most of the resources.
b) While most existing databases permit querying with
gene symbols (e.g., PRM1) or complete names (e.g., pro-
tamine 1), very few databases allow the user to success-
fully use the names of cell types, tissues, or specific
physiological conditions, as query terms. More impor-
tantly, whenever such queries are allowed, the
corresponding results do not seem to be reliable
(Acharya et al, unpublished).
c) Many databases focus on the relative expressions of
genes across two conditions and/or the level of expres-
sion of genes. This type of information is difficult to
compare across data-sets. Hence, most existing data-
bases simply provide access to the original data, or
represent it graphically, rather than making a final
statement about the expression/transcription status of
genes under various conditions. Somehow, the value of
a simple expression statement in a binary form (i.e.,
expressed or not expressed) is apparently ignored by
most existing databases.
In view of such limitations in the available online
resources, we have initiated a novel approach to create
tissue-specific databases by making maximum use of the
available information and facilitate the prediction of
gene expression patterns under various conditions.
The current article reports creation of the first of its
kind tissue-specific database for predicting gene expres-
sion patterns. Our objective was to collect maximum
gene expression data-sets corresponding to a specific
tissue, and enable identification of genes with consistent
expression status across multiple studies corresponding
to specific conditions/cell-types. The consensus expres-
sion status derived for genes using such an approach
was expected to largely agree with manually curated
data (MCD), particularly in cases where the information
is supported by multiple small scale studies. The perfor-
mance of the new database was compared with several
existing resources. Testis, where the cell differentiation
is unique among adult tissues, was taken as the first
tissue for database creation.
Methods
The strategy can be summarized as follows: a) Collect
maximum amount of genome-wide expression data,
including smaller gene-lists reported in the manuscripts,
corresponding to the mammalian testis tissue. b) Create
a database using these data. The database would have
multiple gene-sets corresponding to the same or similar
physiological and/or experimental conditions. c) Mea-
sure the extent of agreement or contradictions for each
gene’s expression status, across comparable gene-sets in
the database. d) Use this degree of consistency to iden-
tify the ‘consensus’ expression status for each gene, for
maximum possible conditions/locations, and derive a
‘reliability-score’ for each consensus expression status.
e) Create interfaces that would allow users (of the data-
base) to easily obtain lists of genes for various testicular
conditions/cell-types, and also differentiate the genes
with higher reliability, from those with low reliability
scores, for a specific expression pattern.
Collection and curation of data
Lists of genes reported to be transcribed or dormant fol-
lowing genome-wide expression studies in testis or spe-
cific testicular cells (spermatogonia, spermatocytes,
spermatids, spermatozoa, Sertoli cells, Leydig cells and
myoid cells) under different conditions were collected.
Two approaches were used to collect such gene-sets,
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of the process in additional file 1):
a) Literature search was performed to collect rele-
vant articles. A search strategy was carefully
designed to select appropriate query terms, search
fields and combinations. The initial PubMed results
were filtered by screening the title of the articles.
Abstracts of the short-listed citations were read to
identify articles of probable relevance (articles that
might report expression of multiple genes in mam-
malian testis or its cell types). These articles were
then searched for the list of genes reported to be
expressed, up-regulated, down-regulated, etc. Origi-
nal complete lists reported in the supplementary
notes (such as the journal web-sites or the author’s
own page) were traced. When this was not possible,
the genes reported to be expressed were extracted
from the main text of the published article.
b) Microarray repositories such as Gene Expression
Omnibus (GEO) [15], ArrayExpress [16], Oncomine,
Stanford Microarray Database (SMD) [17] and Cen-
ter for Information Biology gene EXpression data-
base (CIBEX) [18] were screened for data-sets
related to mammalian testis. The search and collec-
tion of data-sets were performed manually. The
data-sets were uploaded into the new database along
with associated details such as the statistical meth-
ods and platforms used in the experiments, using a
specially designed excel-based format. Newly created
programs (please see below) extracted the contents
of such files, including genes and their expression
status, into designated tables of the database.
Author/depositor-calls on the expression status were
used. No additional analyses were performed.
Each gene-set was collected along with the necessary
cognate information, such as,
1. the expression status (expressed or dormant),
2. species,
3. tissue-area or cell type, and
4. specific physiological or experimental condition.
This set of basic parameters is henceforth referred to
as ‘Expression Status under specific Location and Condi-
tion (ESLC)’.T h e‘conditions’ include normal physiolo-
gical state, diseases, developmental stages and treatment
with hormones and/or other chemicals. This type of
information and the corresponding gene-set were sys-
tematically formatted and entered into the database. No
attempts were made to perform fresh statistical analysis.
Instead, the ‘expressed’ or ‘not expressed’ call by the
author(s) was relied upon. In any study with multiple
hybridizations, the expression status indicated in the
majority of cases was used as the final expression status.
For example, any gene reported to be ‘expressed’ in the
majority of the hybridizations/samples was identified as
‘expressed’. In several cases, the gene-sets reported by
the authors had to be split into multiple gene-lists (see
additional file 1 for an example). Thus, several gene-sets
were collected, each ranging in size from three genes to
several thousand genes. Each gene-set was characterized
by the transcription, or lack of it, in specific location
and condition.
A scoring system was used to suggest the degree of
reliability of the ESLC
For every ESLC, a score was derived for each gene and
added up across comparable gene-sets to indicate the
reliability of that ESLC. This ‘reliability score’ reflected
the consensus expression status across multiple gene-
sets. Each gene was assigned a score of two for a specific
and definite expression status (transcribed or dormant).
W h e nt h ee v i d e n c ef o ra nE S L Co fag e n ei n c r e a s e d ,
across the gene-sets, the score increased. For example, a
gene reported to be ‘not detected’ in normal rat testis by
two studies, would be shown as ‘dormant’ in normal rat
testis with a reliability-score of four. Thus, a lower score
would indicate either lack of supporting evidences or pre-
sence of contradicting reports for the specific expression
status under consideration (details in additional file 2).
Database creation (see additional file 3)
MySQL Relational Data-Base Management System
(RDBMS) was employed for storing data. A table was
dedicated to store the basic gene-related information
including the gene name, locus and transcript details.
Another table was used to store gene identifiers such as
gene name, gene description, official gene symbol and
the National Center for Biotechnology Information
(NCBI) gene identifier etc. There are also tables corre-
sponding to each main expression condition: each table
was created to store the genes with the derived expres-
sion status along with details pertaining to their ESLC’s.
Perl based CGI script has been used to create an
interface for entry of gene-lists. Programs were written
for automatic downloading of basic information for
every new gene entered into the database. Another pro-
gram used the available identifier for each gene in the
uploaded gene-set, and retrieved its respective NCBI
gene identifier and the gene symbol. After the basic
information compilation, the genes were put in queue
for further information downloading from online
resources, followed by uploading into the new database.
Specially designed Perl programs such as LWP modules
(http://search.cpan.org/~gaas/libwww-perl-5.836/lib/
LWP.pm) were used to connect to NCBI and, with the
aid of NCBI E-utilities (http://eutils.ncbi.nlm.nih.gov/
entrez/query/static/eutils_help.html), the required
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the NCBI gene id, official gene symbol, aliases, gene
sequence, gene summary, chromosomal location, poten-
tial promoter sequence [-1000 to +200 bp] and all
transcript sequences (along with exon-intron details)
corresponding to each gene. Using gene symbol and
Swiss-Prot IDs downloaded from NCBI gene database,
protein-related information encoded by that gene was
downloaded from Swiss-Prot [19] (http://ca.expasy.org/
sprot). Similarly, transcription start sites were down-
loaded from dbTSS [20] (ftp://ftp.hgc.jp/pub/hgc/db/
dbtss/). When the information was not available in
dbTSS for a gene, the 5’ end of corresponding NCBI
RefSeq sequences (transcripts) was used to represent the
TSS position. Perl codes were written to ensure auto-
matic incorporation of the downloaded data into the
database.
Comparison of MGEx-Tdb with other existing resources
Initially several databases were considered for compari-
son (details in additional file 4). But only UniGene,
BioGPS and HPRD were selected and compared in
detail as described below.
Assessing the degree of agreement of gene expression
status between the databases and the manually curated
data (MCD)
Literature search was performed to compile reports on
expression status of 60 human genes, which were ran-
domly chosen (to avoid bias, MGEx-Tdb was not used
as source). Selected articles corresponding to these
genes were read in detail and evidences were collected
for certain ESLCs. The focus was on studies that
addressed the expression of one or a few genes only.
Mass scale studies such as genome-wide expression pro-
filing studies, which were used to create MGEx-Tdb,
were avoided. More than one independent experimental
evidence for the same expression status, by at least two
separate studies, were available for 13 of the 60 chosen
genes (see additional file 5).
The expression status was obtained from the newly
developed database as well as from UniGene, BioGPS
and HPRD, for each of the 13 genes. This information
was compared with the unanimous expression pattern
derived from MCD, and scores were then assigned to
indicate the extent of agreement (see additional file 6
for scoring details). Each database was thus scored for
concurrence with MCD for the 13 genes. This exercise
was performed independently by two individuals and the
results were concurrent (see additional file 7 for details).
Coverage of the databases
The number of genes for which the databases could
provide expression status was noted. A total of 110
human genes were used (i.e., 50 more randomly chosen
genes added to the list of earlier selected 60 genes).
E v e r yd a t a b a s ew a sg i v e nas c o r eo fo n ew h e nag e n e
was present in the database, and an additional score of
one if the expression information for that gene is also
present in the database. Thus, the maximum total score
a database could get was 220.
Final in silico validation of the database (see additional
file 8 for details)
Ten different genes reported to be predominantly
expressed in mammalian testicular cells were taken and
compared for two aspects as described below.
a) Relative amount of information per gene: Every
database was scored for availability of information for
each gene’s expression in testis, in specific cell type,
condition and in different species (mouse, rat and
human).
b) Agreement of each gene’s information from data-
base with that of the information available in the litera-
ture: For this comparison, a procedure similar to the
one used above (in the case of MCD vs. database com-
parison) was employed.
Results
A database with a total of 62,185 genes has been cre-
ated. The genes were derived from 769 gene-sets, which
in turn were collected from online resources like
ArrayExpress, GEO as well as, from publications
(table 1). The new database provides 19 different ESLC
for humans (25,158 genes), 74 for mice (22,919 genes)
and 26 for rats (14,108 genes).
While cancer-related mass scale gene expression pro-
filing have almost been exclusive to humans, studies on
hormone treatment and gene knock-outs were more
common in mice. Chemical treatment studies have been
very frequent in rats. In addition, the newly created plat-
form has the potential to indicate the expression pattern
of a gene in about 36 different tissues under normal
conditions.
The gene-sets in the new database are predominantly
transcript-lists from microarray studies. Mass scale stu-
dies were rare for testicular cell types in humans unlike
Table 1 The contribution of the number of gene-sets
from each resource across species
No. of gene-sets*
Resources Human Mouse Rat
ArrayExpress 36 (15537) 9 (11438) 45 (10452)
GEO 131 (6337) 302 (6359) 24 (8594)
PubMed 43 (225) 138 (3791) 41 (1116)
Total 210 (7366) 449 (7196) 110 (6721)
*The value in parenthesis represents average gene count across the gene-sets.
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uploaded in the database have more than 500 genes
each, but smaller gene-lists reported in manuscripts,
have also been included in this database (Figure 1).
Multiple gene-sets were indeed collected for certain
conditions. For example, 124 gene-sets were collected
for testicular cancer in humans from 7 reports, 35 gene-
sets for normal human testis from 13 reports and 6
gene-sets for mouse spermatids from 5 reports. There
are about 21 ESLCs, for each of which at least 2 differ-
ent studies were compiled. Such comparable gene-sets
were particularly useful in deriving a consensus of
expression patterns and reliability-scores. However,
there were many cases where we could get only one
research article per condition such as adjudin and cad-
mium chloride studies in rat, with 6 gene-sets each.
During the comparative study, HPRD showed a better
agreement with MCD (as shown in table 2) than other
databases. However, it had the lowest coverage for
human genes among the databases considered, with a
score of 204. UniGene obtained 219, whereas MGEx-
Tdb and BioGPS got the maximum possible 220 for
c o v e r a g e .I ts h o u l db en o t e dt h a tH P R Di sm a i n l ya
human protein database, with focus on multiple aspects
of proteins. Unlike other databases considered, HPRD
provides the expression status that is established by
manual curation of small-scale studies, at protein as well
as mRNA levels. Hence, the higher agreement (see
tables 2 and 3) with MCD as well as the lower coverage
of HPRD is not surprising.
MGEx-Tdb performed better, than other databases
considered, in predicting the expression status of genes,
when queried with various physiological conditions (see
table 4, also see additional file 9 for methods). Even
when queried with specific genes, MGEx-Tdb provided
much more details (see table 3 and additional file 8).
This new database also provided transcription informa-
tion for more genes in the context of developmental
stages, compared to the databases specialized for devel-
opment-related gene expression patterns (see table 5,
also see additional file 9 for methods).
As expected, the tissue-specific compilation of mass-
scale gene expression data resulted in agreement with
MCD (individual gene studies, see table 2). MGEx-Tdb
was as good as, or better than, UniGene and BioGPS, in
terms of agreement with MCD. Since the results from
HPRD agreed completely with MCD for 8 of the 13
query genes, it attained the highest % score for agree-
ment with MCD as shown in table 2. This is despite the
fact that HPRD showed only partial agreement with
MCD for 3 genes, did not provide expression-related
information for 1 gene and lacked any information for
another.
The newly created platform is also able to successfully
separate the genes, which show consistent transcription
status across the gene-sets/studies from those which do
not. For example, using the output of MGEx-Tdb in
case of testicular cancer, one can not only identify 8,410
transcribed and 8,207 dormant genes, but also categor-
ize them further based on the reliability-score. Of the
8,410 genes, 674 had a reliability-score greater than 70,
indicating that they have a higher probability of being
expressed in human testicular cancer conditions. Simi-
larly, 2,729 genes had a reliability-score between 10 and
70, while 1555 showed a score of 4 or less. In another
example of 7,570 genes transcribed in 14 day old mice,
875 had a reliability-score of ≥6 and 2291 genes had a
score of 2.
Overall, MGEx-Tdb could offer the following advan-
tages over the other databases analyzed: a) more useful
query features, b) reliability of information provided, as
indicated by high agreement with MCD, c) better output
in terms of the number of genes, and d) the unique
reliability indicator for each gene, under different ESLC.
This new database did not agree with MCD to the same
extent as HPRD, but showed better coverage and higher
number of genes in the output for disease-related query.
An overview of MGEx-Tdb usage is provided in the
form of screen-shots in the additional file 10.
Figure 1 Categorization of gene-sets in MGEx-Tdb based on
the ‘number of genes per gene-set’. For example, there are 52
small gene-sets (each with less than 20 genes) and of these, 51
sets have been retrieved from literature.
Table 2 Extent of agreement for gene expression pattern
of 13 genes, between MCD and the databases
Database Score (maximum = 26) % agreement with
reports on individual
gene studies
HPRD 20 77
MGEx-Tdb 14 54
UniGene 12 46
BioGPS 11 42
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Researchers have been trying to compile and compare
microarray data from different studies. ArrayExpress,
TranscriptomeBrowser [21], Genevestigator [22] and
COXPRESdb [23] are some examples. Variations in
experimental conditions across studies have hindered
such efforts. Recommendations for systematic reporting
of experimental conditions [24,25] and new methods for
cross-platform comparisons of microarray results [9,26]
have improved our ability to make use of the available
microarray data. However, many microarray data-sets
are not comparable due to various reasons. These rea-
sons include non-compliance with MIAME [27] and
complications in statistical methods of data processing,
particularly when the studies have used different micro-
array platforms [7]. There are also a large number of
reports where raw data is not available and only selected
genes with specific expression pattern are listed. Such
gene-lists lack the necessary basic information for com-
paring expression level-related information.
The method reported here allows comparison of the
gene-sets irrespective of associated information such as
intensity values, statistics, platform and probes.
Obviously, this simplification would mean loss of other
important information such as relative up/down regula-
tion and levels of expression. Many ‘meta-analysis’
approaches have considered such details of expression
data [28,29], but they are applicable to raw data only. It
is also difficult to find consensus by the traditional
methods. For example, if a study (A) finds gene xyz to
be expressed very high in condition 1 (C1) compared to
condition 2 (C2), study B finds xyz to be expressed only
marginally higher in C1 than in C2, and study C finds it
to be expressed almost equal in both C1 and C2 - they
all disagree with each other as far as the ‘relative levels
of expression’ is considered. The novelty of our
approach is that, by considering only the ‘transcribed’ or
‘dormant’ status, the data could be compiled across dif-
ferent microarray platforms, and we can state that gene
xyz is ‘present’ in C1. Thus, this method of comparing
expression status in a binary form allows use of most of
the available microarray data, including simple gene-
lists.
In fact, obtaining a list of genes expressed or not
expressed in specific conditions, and deriving consensus
across studies, can provide an extremely important alter-
native to biomarker identification. Generally, the genes
that are up regulated or down regulated and those
Table 3 Relative assessment of amount and details of information, and agreement with MCD
Database Information availability and volume of supporting data Agreement with reports on individual gene studies
Score (maximum = 33) % score Score (maximum = 11) % agreement
HPRD* 13 39 8 73
MGEX-Tdb 27 82 5 45
UniGene 14 42 3 27
BioGPS 11 33 5 45
Notes:
See additional file 8 for detailed methods;
*HPRD is specific for humans. Hence the score depicted for this database is not an average across the species.
Table 4 Results in response to queries for expression status of genes under different testicular conditions
No. of genes retrieved in response to different queries
Database
1 Normal testis
(human)
Azoospermia
(human)
Asthenozoospermia
(human)
Testicular
cancer
2 (human)
Adjudin
treatment (rat)
Developmental stage-
postnatal (mouse)
MGEx-Tdb 12753 5215 10 16617 10982 15209 (day 14)
BioGPS
3 403 14 0 3 0 2
RefExA
4 92 3 0 3 NA NA
TissueDistributionDBs
4 16124 4 0 2 0 0
UniGene
4 18421 4 0 194 0 1
5
HPRD 4249 2 0 0 NA NA
Notes:
See additional file 9 for detailed methods;
NA: Not Applicable, i.e., data restricted to humans only in these databases;
1The URLs are listed in the additional file 4.
2Querying with testis AND cancer retrieved 116 genes in BioGPS; “Germ cell cancer” in testis retrieved 9655 genes (10042 hits) in TissueDistributionDBs and
“Germ cell tumor” in testis retrieved 14874 genes (18130 hits) in UniGene and 2 genes in HPRD.
3Includes results from human, mouse & rat species (search can not be restricted to specific species).
4Number of genes in the results corresponding to different queries: probe names in case of RefExA & cluster IDs in case of UniGene & TissueDistributionDBs.
5Querying with alternative equivalent terms of postnatal (neonate) retrieved 10467 genes (11519 hits) in UniGene.
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ered as possible markers. With the new approach one
can compare the list of genes with high reliability score
for the ‘expressed status’ under a normal condition with
a similar set of genes absent in an abnormal condition.
The union list derived after such a comparison would
h a v eau n i q u ev a l u ea sas e to fp o t e n t i a lb i o m a r k e r s .
Similarly, genes that are more likely to be dormant in
normal conditions, but expressed in abnormal tissues
would also be important. We are currently trying to use
this approach to identify genes that have a strong corre-
lation with azoospermia.
Nevertheless, the current database can also be used as
as i n g l es o u r c ef o ri d e n t i f y i n gm o s to ft h em a s ss c a l e
gene expression data as it directs the user to the original
data in all cases. Those interested in using the original
microarray data can do so, and perform their own com-
parison and analysis.
Approaches similar to the one used in this study have
been used for other purposes earlier too: Smith et al.
[30] applied such a method for meta-analysis of breast
cancer microarray data and Harsha et al. [31] for identi-
fying potential pancreatic-cancer biomarkers. Very
recently, Culhane et al. [32] also reported a very similar
approach to create a gene expression database, Gene-
SigDB, which considers gene lists from tables or figures
embedded in publications or included as supplementary
material on the journal’so rt h ea u t h o r ’sw e b s i t e .B u t ,
GeneSigDB does not use raw data, cover testis-related
conditions or derive a consensus across data-sets (from
different studies). New methods such as Gene Set
Enrichment Analysis (GSEA) [33], Parametric Analysis
of Gene set Enrichment (PAGE) [34] and Generally
Applicable Gene set Enrichment for pathway analysis
(GAGE) [35] process data across multiple data-sets in
such a way that, the specific details of data-processing
within each study are not required to bring out mean-
ingful information from the microarray experiments.
However, the objective of GSEA and PAGE was to gain
insights into biological mechanisms by clustering genes
across studies, while our focus was in deriving the con-
sensus information along with a reliability score.
Compilation of gene-sets corresponding to comparable
conditions and locations, and deriving a reliable ESLC
for each gene, can be useful in various ways. One can
cluster genes based on their expression pattern in differ-
ent ESLCs. Such clustering can help to identify genes
having strong association with specific conditions and/
or locations. For example, genes with consistent expres-
sion in normal testis but absent in infertility conditions
might be of significance for researchers. The higher the
reliability-score of a gene, the higher will be its chances
of being a biomarker and/or a candidate for research in
diagnostics, prognostics and therapeutics. Moreover, tis-
sue-specific databases, such as MGEx-Tdb, also have the
potential to assist in exploring the variation or conserva-
tion of expression of genes across different species in
multiple tissues.
The need for systematically compiling gene-expression
data in one place is obvious from previous efforts. In
fact, TisGeD [36], a new database, has been reported
during the last stages of the writing of this manuscript.
This database is a compilation of data for most tissues
and species, mainly from existing databases. But it
seems to have failed to make the best use of all available
information, at least for the testis tissue. On the con-
trary, an effort like the current one may not be always
practical. The biocuration process consumed a signifi-
cant amount of time (about 3 years) and is eventually
limited to only one tissue. However, it would provide
more reliable information. There is perhaps a compro-
mised approach possible. While about 222 gene-sets in
the database were retrieved from literature, 156 of them
had less than 500 genes per set. By avoiding such smal-
ler gene-sets, one might save time - albeit with some
loss of information.
Even though this study has compared MGEx-Tdb with
a few well-established databases, the purpose is of
course not to undermine the value of these pre-existing
resources. Such databases have their own specific advan-
tages and, in many cases, a wider variety of applications.
The objective of comparing the different databases was
to validate the novel approach.
While MGEx-Tdb can facilitate unique applications in
the gene expression studies in the context of
Table 5 Results for expression status of genes at
developmental stages in mouse testis from different
databases.
Databases
1 Postnatal period Specific postnatal Stage
(0-6 day/TS27)
MGEx-Tdb 21016
2 21195
Bgee 15899 15501
MGI (GXD) 5954
3 NA
MRG ~8500 ~8500
4DXpress ND ND
Notes:
See additional file 9 for detailed methods;
NA: Not Applicable, i.e., no query feature available for early post-natal stages
of development; ND: No Data in postnatal development stage [available till TS
26 only]; TS: Theiler stage (A term used to denote the stage of development
of a mouse; Theiler, 1989); Bgee: a dataBase for Gene Expression Evolution;
MGI (GXD): Mouse Genome Informatics (Gene Expression Database); MRG:
Mammalian Reproductive Genetics; 4DXpress: EXpression database in 4D (four
dimensions).
1The references and URLs are listed in the additional file 4.
2MGEx-Tdb results correspond to genes transcribed/dormant on specific days
between day 0-20 and many genes cancel due to contradictory results.
However, one can obtain better results for specific stage using this database,
as indicated in the third column.
3The results include some repeats.
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scope for further improvement in different aspects. For
example, incorporation of level of expression along with
the basic expression status might be possible in many
cases. The method of calculating ‘reliability-scores’ for
the expression patterns can be improvised by consider-
ing the details such as sample size and validation of the
microarray data, reported along with gene-sets. Factors
such as unavailability of complete data in many cases,
diversity in analytical methods used, and lack of experi-
mental details in many of the published gene expression
studies have been major hurdles for the compilation of
parameters mentioned above. Nevertheless, we are
already making attempts to make the possible improve-
ments. We are also trying to include data from other
types of mass scale studies. In the current database, we
have used the non-microarray data in some cases only,
particularly when a list of genes was reported in the
manuscript or in the supplementary notes. The data in
the repositories could not be included due to complica-
tions in the process of converting the unique identifiers
(e.g., SAGE tags) to standard gene names or ids. We
shall complete these tasks in a revised version of the
database. Moreover, efforts are on to include data from
more mammalian species for the testis tissue, further
improve query features of this database and even
develop a few other tissue-specific databases.
M o s to ft h ee x i s t i n gd a t ap e r m i to n l yp r e d i c t i o n s ,
rather than actually establishing a final expression status
for different genes. This can be explained as follows: a)
There is a larger amount of data available for the
expression of genes at the RNA level, compared to pro-
tein level, and transcription doesn’t guarantee continued
translation into proteins. Thus, the mRNA data can only
be used to suggest or predict the expression of genes
into final proteins. b) The expression status of some
genes can vary across samples, even within a study. The
genes which behave the same way across samples and
studies are more likely to have a stronger association
with the physiological condition of the tissue/cell type of
interest. This means, the data can only be used to pre-
dict the expression possibilities. And, it will be useful to
‘predict’ expression patterns of genes, using a reliability-
score such as the one reported here.
Conclusions
We demonstrate that manual collection of mass scale
gene expression data will allow derivation of a ‘reliability
score’ for binary expression status of genes. The simpli-
city of the new approach permits consideration of
expression data obtained using ESTs, SAGE, Massively
Parallel Serial Sequencing (MPSS), proteomics and other
techniques as well. This way, maximum amount of
existing data can be used for better prediction of gene
expression patterns across a variety of reports. We also
report the mammalian testis specific gene expression
database, which performed better than most other gene
expression databases in various aspects. MGEx-Tdb is
the first database that attempts to make maximum use
of the available data to provide a quantitative indicator
for the expression-probability of genes under multiple
conditions and locations, in the context of at least one
mammalian tissue. We are further improving the scor-
ing method and enhancing the volume of relevant gene
expression data. MGEx-Tdb can be used for easy retrie-
val of information about expression of genes in several
conditions of testis or its cell types in 3 most well-stu-
died mammalian species. This in turn can be very useful
for identifying potential biomarkers and studying mole-
cular details of mammalian testis physiology.
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